Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Onconova Therapeutics, Inc. (ONTX)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15
   8-K10-K10-K10-K10-K10-K10-K10-K
Net income  -19.0-16.2-25.2-21.5-20.6-24.1-19.7-24.0
Depreciation and amortization   0.00.00.00.10.10.10.2
Stock-based compensation   0.60.41.01.11.73.93.8
Change in working capital   [+] -3.41.7-0.1-0.50.63.8-11.2
Other operating activities   -0.50.0-0.3-2.8-2.1-4.00.0
Cash from operations   -19.5-23.1-20.8-22.7-23.8-15.8-31.2
   
Capital expenditures   0.00.0-0.10.00.00.00.0
Cash from investing   0.00.0-0.10.00.00.00.0
   
Issuance of common stock, net   55.09.121.835.1   
Option exercises   0.0  0.6 0.0 
Other cash from financing   0.510.34.91.26.417.4 
Cash from financing   55.619.426.635.76.417.40.0
   
Free cash flow   -19.5-23.1-20.9-22.7-23.8-15.8-31.2
        Per share (diluted)   ($1.16)($1.99)($1.45)($5.50)($39.70)($3.57)($13.74)

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy